RUTKA v. TAMAKI

CourtDistrict Court, D. Maine
DecidedFebruary 7, 2023
Docket2:21-cv-00180
StatusUnknown

This text of RUTKA v. TAMAKI (RUTKA v. TAMAKI) is published on Counsel Stack Legal Research, covering District Court, D. Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
RUTKA v. TAMAKI, (D. Me. 2023).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MAINE

ERIK RUTKA, as Personal ) Representative of the Estate of ) Jennifer Rutka, ) ) Plaintiff ) ) v. ) 2:21-cv-00180-JCN ) ATSUSHI TAMAKI, ) ) Defendant )

ORDER ON PLAINTIFF’S MOTIONS IN LIMINE

Plaintiff moves in limine for an order that permits (1) two experts to testify at trial by videoconference (Motion, ECF No. 62), and (2) Plaintiff to present testimony and documents that include statements of Jennifer Rutka and others. (Motion, ECF No. 63). The Court discussed the motions with the parties during a telephonic conference on February 3, 2023. After consideration of the parties’ arguments, for the reasons set forth herein and stated on the record during the telephonic conference, the Court grants in part and denies in part the motions. DISCUSSION

I. Expert Testimony Plaintiff designated two expert witnesses—Ms. Rutka’s treating psychologists, Kathryn Chun, Ph.D and Kristin Christensen, Ph.D—and now asks the Court to allow the witnesses offer certain opinions at trial and to authorize the witnesses to testify remotely by videoconference. Defendant opposes the motion citing the lack of foundation for and relevance of the proffered opinions, and Plaintiff’s failure to establish that good cause and compelling circumstances exist for the experts to testify remotely. Federal Rule of Evidence 702 permits a qualified expert to offer an opinion if:

(a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. Fed. R. Evid. 702. “[T]he judge’s task is to ensure that the expert’s testimony ‘both rests on a reliable foundation and is relevant to the task at hand.’ ” Pagés-Ramírez v. Ramírez- González, 605 F.3d 109, 115 (1st Cir. 2010) (quoting United States v. Mooney, 315 F.3d 54, 62 (1st Cir. 2002)); see also Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579, 597 (1993). In doing so, the Court “must bear in mind that an expert with appropriate credentials and an appropriate foundation for the opinion at issue must be permitted to present testimony as long as the testimony has a ‘tendency to make the existence of any fact that is of consequence to the determination of the action more probable or less probable than it would be without the evidence.’” Pagés-Ramírez, 605 F.3d at 115 (quoting Fed. R. Evid. 401). Plaintiff designated Dr. Chun to testify about the impact on Ms. Rutka of the alleged sexual abuse. Dr. Chun treated Ms. Rutka in 2014–2015, years after the abuse allegedly occurred. Dr. Christensen, with whom Ms. Rutka started counseling near the time she initiated this lawsuit, was also designated to testify about the impact of the sexual abuse on Ms. Rutka. Defendant does not challenge either expert’s qualifications. Defendant argues that Dr. Chun’s work with Ms. Rutka “was limited and not directed to anything related to Defendant” because Dr. Chun’s work with Ms. Rutka focused on Ms. Rutka’s relationships and experience as a parent. Based on Plaintiff’s

proffer and arguments, the Court understands Dr. Chun will testify that the alleged sexual abuse by Defendant had a significant and long-term negative impact on Ms. Rutka in multiple ways, including in her relationships. Such testimony would be relevant and would assist the jury in understanding the impact of abuse. To the extent Defendant maintains Dr. Chun’s testimony is not relevant, therefore, Defendant’s argument is unavailing.

Defendant also argues that the testimony of Dr. Chun and Dr. Christensen should be excluded because, during their depositions, both witnesses testified only that the sexual abuse “possibly” caused Ms. Rutka’s claimed damages. Expert testimony may be excluded if there is ‘too great an analytical gap between the data and the opinion proffered.’” Milward v. Acuity Specialty Prods. Grp., Inc., 639 F.3d 11, 15 (1st Cir. 2011) (quoting Gen.

Elec. Co. v. Joiner, 522 U.S. 136, 146 (1997)). “The question of admissibility ‘must be tied to the facts of a particular case.’” Beaudette v. Louisville Ladder, Inc., 462 F.3d 22, 25–26 (1st Cir. 2006) (quoting Kumho Tire Co. v. Carmichael, 526 U.S. 137, 150 (1999)). The Court acknowledges that at various points in the limited deposition testimony of record, the expert witnesses described the causal relationship between the alleged abuse

and Plaintiff’s challenges as “possible.” Dr. Chun, however, also testified that some of the issues Ms. Rutka experienced “were related to” the sexual abuse and that “it was possible and probable” the problems were “because of the significance of that traumatic experience.” (Def.’s Opp’n to Pl.’s Mot. in Lim. for the Admis. of Expert Witness Test., Ex. B, Chun Dep. Tr. 76:21–77:15, ECF 82-2.) Likewise, Dr. Christensen opined that “oftentimes” low frustration tolerance can be caused by sexual abuse, and that some of the issues Ms. Rutka experienced as an adult “most likely . . . did come from sexual abuse.” (Def.’s Opp’n to

Pl.’s Mot. in Lim. for the Admis. of Expert Witness Test., Ex. C, Christensen Dep. 48:22– 49:21, ECF 82-3.) While the experts might be unable to link to the alleged abuse all the conditions for which they counseled Ms. Rutka, the deposition testimony suggests they will provide testimony from which a factfinder can properly find a causal relationship between some of Ms. Rutka’s conditions and the alleged abuse. To the extent Defendant

can demonstrate some inconsistency in the testimony, “it is a matter for the jury to resolve any inconsistencies in expert testimony.” Payton v. Abbott Labs, 780 F.2d 147, 156 (1st Cir. 1985). Plaintiff’s filings suggest he might attempt to elicit expert testimony regarding the relationship between the alleged abuse and the timing of Ms. Rutka’s commencement of

this action. Regardless of whether such testimony might be admissible under certain circumstances, Plaintiff’s expert designation did not notify Defendant that the expert witnesses would testify on the issue. As Defendant points out, Plaintiff was required to disclose that information under Rule 26(a)(2) of the Federal Rules of Civil Procedure. “A party seeking to introduce expert

testimony at trial must disclose to the opposing party a written report that includes ‘a complete statement of all opinions the witness will express and the basis and reasons for them.’ ” Gay v. Stonebridge Life Ins. Co., 660 F.3d 58, 62 (1st Cir. 2011) (quoting Fed. R. Civ. P.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mutual Life Insurance v. Hillmon
145 U.S. 285 (Supreme Court, 1892)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
General Electric Co. v. Joiner
522 U.S. 136 (Supreme Court, 1997)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
United States v. Kaiser
609 F.3d 556 (Second Circuit, 2010)
United States v. Mooney
315 F.3d 54 (First Circuit, 2002)
Poulis Minott v. Smith
388 F.3d 354 (First Circuit, 2004)
Beaudette v. Louisville Ladder, Inc.
462 F.3d 22 (First Circuit, 2006)
Milward v. Acuity Specialty Products Group, Inc.
639 F.3d 11 (First Circuit, 2011)
Brenda Payton v. Abbott Labs, Eli Lilly and Company
780 F.2d 147 (First Circuit, 1985)
Gay v. Stonebridge Life Insurance
660 F.3d 58 (First Circuit, 2011)
Pagés-Ramírez v. Ramírez-González
605 F.3d 109 (First Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
RUTKA v. TAMAKI, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rutka-v-tamaki-med-2023.